Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Apollomics Insiders Buying or Selling?
Apollomics (APLM) has had 5 insider transactions in the past 90 days, all buys — insider buying is generally read as a bullish signal. The most recent was Hung-Wen Chen, who bought 266,667 shares at $15.00 on August 14, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the APLM AI Score. For government officials trading this stock, see APLM congressional trading.
Who’s Trading Apollomics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Hung-Wen Chen | Bought $7.6M | 3 | Aug 14, 2026 |
| LIN PETER KUAN-HOW | Bought $400,000 | 1 | Aug 14, 2026 |
| Yi-Kuei Chen | Bought $300,000 | 1 | Aug 14, 2026 |
Recent Apollomics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Hung-Wen Chen | Aug 14, 2026 | Buy | 266,667 | $15 | $4M |
| Hung-Wen Chen | Aug 14, 2026 | Buy | 166,667 | $12 | $2M |
| Hung-Wen Chen | Aug 14, 2026 | Buy | 103,333 | $15 | $1.5M |
| Yi-Kuei Chen | Aug 14, 2026 | Buy | 20,000 | $15 | $300,000 |
| LIN PETER KUAN-HOW | Aug 14, 2026 | Buy | 26,667 | $15 | $400,000 |
Frequently Asked Questions: Apollomics Insider Trading
In the past 90 days, Apollomics insiders have made 5 buys and 0 sells. The net buying may indicate insider confidence in the company’s outlook.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Chen Hung-Wen has bought the most APLM stock in the last 2 years, with a total value of $7.6M.
According to our estimates, the total value of insider transactions for Apollomics in the last 2 years is positive, amounting to $8.3M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
